Uso de bevacizumab en la telangiectasia hemorrágica hereditaria: reporte de caso

Autor: González Viñas, Darío, Esteban Martín, Faragó, Medrano Baque, Tayli Eumiliana, De Mori Gómez, André Alessandro, Murillo Alava, Holger Heraldo, Toapanta Rea, Ingrid Mariela

Publikováno v: QhaliKay Revista de Ciencias de la Salud ISSN 2588-0608; Vol. 6 Núm. 2 (2022): Mayo-Agosto; 1-11
QhaliKay. Revista de Ciencias de la Salud ISSN: 2588-0608; Vol. 6 No. 2 (2022): Mayo-Agosto; 1-11

Hereditary hemorrhagic telangiectasia, is an autosomal dominant disorder that leads to the formation of dysplastic blood vessels on mucocutaneous surfaces, it can also develop within internal organs, such as the lungs, brain, liver, and gastrointesti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=revistmanabi::47572d289afd8fc8f8efb4efcd818f2a
https://revistas.utm.edu.ec/index.php/QhaliKay/article/view/4460